药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
4-Methoxyamphetamine
Olodaterol
The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Fostemsavir.
4-Methoxyamphetamine
Flumequine
The risk or severity of QTc prolongation can be increased when Flumequine is combined with Fostemsavir.
4-Methoxyamphetamine
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Fostemsavir.
4-Methoxyamphetamine
Eribulin
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Fostemsavir.
4-Methoxyamphetamine
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Fostemsavir.
4-Methoxyamphetamine
Bupranolol
The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Fostemsavir.
4-Methoxyamphetamine
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Fostemsavir.
4-Methoxyamphetamine
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Fostemsavir.
4-Methoxyamphetamine
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Fostemsavir.
4-Methoxyamphetamine
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Fostemsavir.
4-Methoxyamphetamine
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Fostemsavir.
4-Methoxyamphetamine
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Fostemsavir.
4-Methoxyamphetamine
Pasireotide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Fostemsavir.
4-Methoxyamphetamine
Cariporide
The risk or severity of QTc prolongation can be increased when Cariporide is combined with Fostemsavir.
4-Methoxyamphetamine
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Fostemsavir.
4-Methoxyamphetamine
Vernakalant
The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Fostemsavir.
4-Methoxyamphetamine
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Fostemsavir.
4-Methoxyamphetamine
Methsuximide
The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Fostemsavir.
4-Methoxyamphetamine
Ezogabine
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Fostemsavir.
4-Methoxyamphetamine
Celiprolol
The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Fostemsavir.